What topics does this cannabis study cover?

This study covers research on: Cancer, THC, CBD.

Where was this research published?

Published in Cancer reports (Hoboken, N.J.) on May 1, 2026.

THC and CBD boost cervical cancer treatment in laboratory studies

Q: What did this research study find?

Researchers tested whether two common cannabinoids—*THC* and *CBD*—could enhance the effectiveness of cisplatin, a traditional chemotherapy drug used to treat cervical cancer. Using laboratory-grown cervical cancer cells (HeLa and SiHa), they found that combining all three compounds together produce

Antiproliferative Effects of Cannabinoids and Cisplatin in Cervical Cancer Cells.

Cancer reports (Hoboken, N.J.) • May 1, 2026 • Moderately Relevant

🤖

AI Summary

Researchers tested whether two common cannabinoids—THC and CBD—could enhance the effectiveness of cisplatin, a traditional chemotherapy drug used to treat cervical cancer. Using laboratory-grown cervical cancer cells (HeLa and SiHa), they found that combining all three compounds together produced significantly stronger cancer-fighting effects than cisplatin alone. The THC-CBD-cisplatin combination triggered apoptosis (programmed cell death) in 53-58% of cancer cells, while causing considerably less damage to healthy control cells at only 32%.

The study revealed multiple mechanisms through which this combination works: the triple therapy induced cell cycle arrest, increased autophagy (a cellular self-destruction process), and importantly, downregulated DNA repair genes (XRCC1 and RAD51) that normally help cancer cells survive. This multi-pronged attack appears to give cervical cancer cells fewer escape routes. Notably, the combination showed greater selectivity for cancer cells over non-cancerous cells, suggesting it might reduce some of the collateral damage associated with traditional chemotherapy.

While these results are encouraging for future cervical cancer treatments, it's important to note this research was conducted in cell culture, not in human patients. The findings suggest that cannabinoid-based combination therapies warrant further investigation as a potential approach to improve cancer treatment outcomes and potentially reduce the severe toxicities associated with chemotherapy alone.

📄 Original Abstract

Cervical cancer remains a leading cause of cancer-related mortality among women globally, particularly in low- and middle-income countries. Cisplatin, a standard chemotherapeutic agent, is limited by severe toxicities and chemoresistance. This study aimed to assess the effects of cisplatin in combination with phytocannabinoids, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on cell proliferation, morphology, cell cycle progression, cell death, and DNA damage. Synergistic interactions between THC, CBD, and cisplatin were assessed in HeLa, SiHa, and MCF-12A cells using the checkerboard assay and SRB assay. Cell morphology, cell cycle progression, apoptosis induction, autophagic activity, and DNA repair gene expression were evaluated using various techniques. The THC-CBD-cisplatin combination exhibited the strongest apoptotic response in cancer cells (HeLa 53%, SiHa 58%), while minimally affecting MCF-12A cells (32%). Cannabinoid co-treatment amplified the antiproliferative and pro-apoptotic effects of cisplatin in HeLa and SiHa cells. The triple combination induced a G2/M arrest in HeLa cells and sub-G1 accumulation in SiHa cells. Autophagic activity, indicated by LC3B puncta formation, increased in HeLa and SiHa cells following THC and CBD exposure. DNA repair genes XRCC1 and RAD51 were downregulated by the cannabinoid-cisplatin combination. These findings demonstrate that combining THC and CBD with cisplatin results in enhanced and mechanistically diverse anticancer effects, with a higher degree of selectivity for cervical cancer cells compared to non-cancerous MCF-12A cells by inducing apoptosis and autophagy while inhibiting DNA repair capacity. This study highlights the potential of cannabinoid-based combination therapies as a promising approach for cervical cancer treatment.

Paper Type

📄 Research

Publication

Journal: Cancer reports (Hoboken, N.J.)
Published: May 1, 2026
PMID: 42055476
DOI: 10.1002/cnr2.70561

Authors (3)

S P Mathibela Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
M T Lebelo Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
V Steenkamp Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

MeSH Keywords

Humans Cisplatin Uterine Cervical Neoplasms Female Cell Proliferation Apoptosis Cannabidiol Drug Synergism HeLa Cells Antineoplastic Combined Chemotherapy Protocols +6 more